Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mingmu Zhiyang Xunxi Fang is a Traditional Chinese Medicine (TCM) herbal formula specifically designed for the treatment of allergic conjunctivitis and other inflammatory ocular conditions characterized by intense itching, redness, and swelling. The formula is administered topically through a specialized procedure involving steam fumigation followed by liquid washing of the eyes, allowing the volatile and active components to penetrate the ocular tissues. It typically comprises a blend of herbs such as *Chrysanthemum morifolium*, *Lonicera japonica*, and *Morus alba*, which are traditionally recognized for their 'heat-clearing' and 'wind-dispelling' properties. Pharmacologically, the formula exhibits potent anti-allergic and anti-inflammatory activities by stabilizing mast cells, inhibiting the release of histamine, and reducing the expression of pro-inflammatory cytokines and adhesion molecules on the ocular surface.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 明目止痒熏洗方.